procurement of some consumable items: inline nebulization system should be capable to generate < 3-micron uniform particle. should be capable of delivering of all clinically certified aerosol drugs, antibiotics & vaccines for neonatal to adult. it should be a fast and silent operating system and easy to setup., inline nebulization machine ( controller system), i. the nebulization unit should operate on vibrating mesh technology to generate uniform particle of 1-5 micron and should be controlled

Health And Family Welfare Department has invited bids for the procurement of some consumable items: inline nebulization system should be capable to generate < 3-micron uniform particle. should be capable of delivering of all clinically certified aerosol drugs, antibiotics & vaccines for neonatal to adult. it should be a fast and silent operating system and easy to setup., inline nebulization machine ( controller system), i. the nebulization unit should operate on vibrating mesh technology to generate uniform particle of 1-5 micron and should be controlled with wired controller., ii. the system should have a microprocessor-based controller to aerosolize the drug through the nebulisation unit., iii. the should be operated with ac/dc adapter (input 100 to 240 vac 50-60 hz, output 9v) or from a usb port on medical electrical equipment., iv. the ac/dc adapter should be warranted against defects in manufacturing for a period of two years from the date of purchase., nebulization chamber with adapter, 1. nebulization unit should be capable of using with multiple modalities like mechanical ventilator, non-invasive ventilator, hfnc/hfov machines, stand-alone nebulisation and continuous nebulization., 2. it should be capable to support nebulization through standard syringe pumps with dedicated / standard luer connectors eliminate the risk of misconnection., 3. drop-by-drop continuous nebulization control with the tubing priming volume range 2- 4ml., 4. the input rate of medication into the nebulization unit under continuous nebulization sgould be in a range of 10-12ml/hr., 5. the standalone nebulization should be used with or without o2 via mouthpiece or mask ., the nebulizer should be validated for single patient use for up to 30 days intermittent use based upon a typical usage profile of 4 treatments per day or 7 days continuous use with the continuous nebulization tube set., for two years from the date of award of contract (aoc)., with an EMD of ₹0.01 Cr. Please refer to the tender document for project value details. Interested bidders can submit applications until 29 October 2026, with the technical opening scheduled for 29 October 2026.